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San Francisco, San Francisco, California 94143; and ~GladstoneInstitute of Virology and 
Immunology, San Francisco, California 94141-9100 
Summary 
T cell activation by antigen/MHC induces the expression :of several genes critical to the im- 
mune response, including interleukin-2. T cells from mice deficient for the NF-KB family 
member c-tel cannot activate IL-2 gene expression. However, mutating the NF-KB site in the 
IL-2 promoter has only moderate ffects. To investigate additional ways c-Rel could regulate 
IL-2 gene expression, we determined whether c-rel overexpression could increase the activity 
of other transcription factors involved in IL-2 promoter regulation: NF-AT, Oct/OAP 
(ARRE-1), and AP-I. In Jurkat TAg cells, overexpression of c-tkel increased AP-1 activation 
-'-'17-fold. Moreover, AP-1 activity stimulated by anti-TCR. Abs or PMA/ionomycin was fur- 
ther increased by c-Rel overexpression, c-lLel overexpression did not affect NF-AT or ARRE-1 
activity. Additionally, overexpression of c-Rel activated the nonconsensus AP-1 site from the 
IL-2 promoter (NF-IL-2B), although to a lesser extent, approximately sixfold. AP-1 activation 
required both the DNA binding and transactivation domains of c-lLel. Our results may provide 
an explanation for the effect on IL-2 gene activation in c-re/--deficient mice. 
T he secretion of IL-2 by activated T cells is an impor- tant step in the initiation of an immune response. The 
primary regulation of IL-2 expression is at the level of tran- 
scription. The IL-2 promoter has been extensively charac- 
terized (for a review, see references 1-3), and contains 
binding sites for several transcription factors, including nu- 
clear factor of activated T cells (NF-AT) 1, NF-KB, AP-1, 
and octamer-binding proteins. The exact nature of the in- 
terplay between these different ranscription factors in the 
induction of IL-2 expression is unknown. Mutagenesis 
studies have demonstrated varying relative contributions of 
different sites within the IL-2 promoter (4). Mutating the 
AP-1 site (NF-IL-2B) decreased promoter expression to 
11% of normal while mutating the distal NF-AT site (NF- 
IL-2E) only decreased IL-2 promoter activity to 31% of 
normal. These suggested that more than one site contrib- 
utes to IL-2 promoter activity. Consistent with this idea, if 
both the octamer sites are disrupted (NF-IL-2A, NF-IL-2D) 
or both the distal and proximal NF-AT sites are disrupted, 
IL-2 promoter activity is effectively abolished (5-7). 
Interestingly, many of the transcription factors that regu- 
late IL-2 gene expression appear to interact at multiple sites 
~Abbreviations used in this paper: Iuc, luciferase; NF-AT, nuclear factor of 
activated T cells; Oct, Octamer; OAP, octamer-associated protein; 
CD28R_E, CD28 response element; GST, glutathione-S transferase. 
withinthe IL-2 promoter. For example, AP-1 family mem- 
bers can directly bind at. the AP-1 site (NF-IL-2B) and are 
also capable of binding at:the NF-AT (8, 9) and at AR.R£-I 
(10) sites in combination with NF-AT and octamer-bind- 
ing proteins. However, mice deficient in c-los (11), c-jun 
(12), NF-KBp50 (3, 13), Oct-2 (3, 14), or NF-ATp (15, 16) 
have no defects in IL-2 gene transcription. Of course, these 
transcription factors are members of large families; the 
knockouts examined may not include the critical family 
member required for IL-2 gene expression or functional 
redundancy within each family may compensate for the 
loss of one member. Consistent with this latter proposal, 
when AP-1 activity is disrupted, not by homologous re- 
combination but by overexpression of a dominant negative 
c-jun, which can presumably block the activity of many AP-1 
components (jun/fos family members), IL-2 gene expres- 
sion is eliminated (17). Similarly, overexpression of a dom- 
inant negative NF-ATc can also block IL-2 gene induction 
(18). However, unlike knockouts of other transcription 
factors, a disruption of the c-Rel gene alone is sufficient o 
eliminate IL-2 gene expression (19). 
c-Rel is a member of the larger NF-KB family, which 
includes p65 (RelA) and p50 (NF-vd31) (for reviews, see 
references 20-22). NF-KB family members all recognize a 
similar decameric motif (initially identified as the KB ele- 
ment in the K-light chain gene intronic enhancer; 23), bind 
DNA as either homo- or heterodimers, and contain a simi- 
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lar structure within their DNA binding and dimerization 
domain, the rel homology domain. In the c-tel-deficient 
mice, although T cell development is normal, mature T cells 
fail to proliferate in response to mitogenic stimuli, such as 
Con A and ant i -CD3/ant i -CD28 (19). c-tel - / -  T cells also 
fail to produce IL-2 upon stimulation with Con A or anti- 
CD3/ant i -CD28,  although other cytokines such as IL-5, 
TNF-0~, and IFN-' , /are affected to a lesser degree (24). The 
proliferative defect can be rescued by addition of  exoge- 
nous IL-2. Therefore, it appears that one critical defect in 
c-tel deficient T cells is the block in IL-2 gene expression. 
However,  the mode of  c-lKel action on the IL-2 promoter 
is not clear, but it is unlikely to be mediated by the NF-KB 
site in the IL-2 promoter. Mutation of the NF-KI3 (NF- 
IL-2C) site had only a moderate ffect on IL-2 promoter 
activity, to 20% of normal (1, 25). Additionally, the NF-KB 
family members that bind to this site in activated T cells 
have been shown to be either p50 homodimers (26) or 
p50/p65 heterodimers (27), and do not appear to contain 
c-lKel. Expression of  both p50 and p65 is normal in c-tel- 
deficient mice. Therefore, it is unlikely that this NF-KB site 
in the IL-2 promoter mediates the defect observed in the 
c-tel-deficient mice. It is not clear whether the CD281KE 
may mediate the effect of  c-R.el on IL-2 gene regulation; 
there is conflicting evidence on the role of NF-KI3 in binding 
and activating transcription from the CD28RE (reviewed 
in references 28, 29). Therefore, the loss of  c-tel might af- 
fect other elements involved in IL-2 gene regulation. 
NF-KB p65 overexpression has been shown to upregu- 
late AP-1 activity (30), and it is possible that c-lKel has sim- 
ilar effects. We have examined the effect o fc -Re l  overexpres- 
sion on NF-AT,  AP-1, and A1KRE-1 (Oct /OAP)  activity. 
c-Rel  dramatically increased activity from a consensus AP-1 
reporter gene, ~17-fold.  Additional increases were seen 
when c-Rel  overexpression was combined with either anti- 
TC1K or PMA/ ionomycin stimulation. However, only min- 
imal effects o fc -Re l  overexpression NF-AT  or ARR.E-1 
reporters were observed, even though both these elements 
contain AP-1 sites, albeit nonconsensus. When the isolated 
AP-1 site from either the distal NF -AT  or A1K1KE-1 sites 
was examined, minimal effects of  c-lKel overexpression was 
observed. It is probable that these sites cannot act indepen- 
dently and require cooperative binding of  either NF-AT  or 
octamer-binding factors. Overexpression of  c-Kel  also in- 
creased activity from a reporter containing the noncon- 
sensus AP-1 site (NF-IL-2B) from the IL-2 promoter, al- 
though to a lesser degree than using a consensus AP-1 
reporter, approximately sixfold, c-Rel  activation of  AP-1 
required both its DNA binding and transcriptional ctiva- 
tion domains. Our results may provide an explanation for 
the lack of  IL-2 expression in c-rel-deficient mice. 
Materials and Methods 
Plasmids. The expression plasmids pCMV4, pCMV4 p65, 
pCMV4 c-rel 1-307, and pCMV4 c-rel 187-587 were previously 
described (31). Reporter constructs were generated by multimer- 
izing oligos into the SalI site of the reporter pAODLO (a gift 
from Dr. B. Starr and Dr. K. Yamamoto). All reporter constructs 
were sequenced to verify number and orientation of inserted oli- 
gos. 4×ARRE luc contains four copies of the AR1KE-1 site from 
the IL-2 promoter in the reverse orientation using the following 
oligos: 
5'-TCGAGTTTGAAAATATGTGTAATATGTAAAACATG-3' 
3'-CAAACTTTTATACACATTATACATTTTGTACAGCT-5' 
4×AP-1 luc contains four copies of the consensus AP-1 site from 
the metallothienein promoter in the reverse orientation using the 
following oligos: 
5'-TCGAGTGACTCAGCGCG-3' 
3'-CACTGAGTCGCGCAGCT-5'  
3×NF-AT luc contains three copies of the distal NF-AT site 
from the IL-2 promoter in the forward orientation using the fol- 
lowing oligos: 
5 '-TCGAGGGAGGAAAA CTGTTTCATACA- 
GAAGGCGTG-3' 
3'-CCCTCCTTTTTGACAAAGTATGTCTTCCG- 
CACAGCT-5' 
3×NF-KB luc contains three copies of the NF-KB site from the 
IL-2 receptor o~ promoter in the reverse orientation using the fol- 
lowing oligos: 
5' -TCGAGACGGCAGGGGAATCTCCCTCTCCG-3'  
3' -CTGCCGTCCCCTTAGAGGGAGAGGCAGCT-5'  
5×AP-I(NF-AT) contains five copies of the AP-1 site from the 
distal NF-AT site of the IL-2 promoter in the reverse orientation 
using the following oligos: 
5'-TCGAGAACTGTTTCATACG-3' 
3'-CTTGACAAAGTATGCAGCT-5' 
4×AP-I(A1K1KE) contains four copies of the AP-1 site from the 
A1K1KE-1 site of the IL-2 promoter in the reverse orientation us- 
ing the following oligos: 
5'-TCGAGATATGTGTAATATG-3' 
3'-CTATACACATTATACAGCT-5' 
4×AP-I(NF-IL-2B) contains four copies of the AP-1/NF-IL-2B 
site from the IL-2 promoter, three in the reverse orientation, and 
one in the forward orientation, using the following oligos: 
5'-TCGACAAAGAGTCATCAG-3' 
3'-GTTTCTCAGTAGTCAGCT-5'  
The site-directed mutants of c-rel, RxxR_xR., and KKK were cre- 
ated using a two-step PC1K-based mutagenesis u ing the proof- 
reading Pwo polymerase (Boehringer Mannheim, Indianapolis, IN). 
These mutations recreate specific site-directed mutations that 
were originally generated in v-rel by Kumar et al. (32). The mu- 
tant RxxlkxlK changes 1K19 to A, 1K22 to A, and 1K24 to A. The 
mutant KKK changes K l l l  to N, Kl12 to Q, and Kl13 to Q. 
After PC1K, the resulting mutants were sequenced to verify that 
the desired changes and no others had occurred. The oligos used 
to generate the mutations were as follows. 
To generate 1KxxRxlK: 
5'-GGCGGGAATGGCTTTTGCATACAAATGTGAAGG- 
GCG-3' 
3' -TAACTTGTTGGGTCCGTCCGCCCTTACCGAAAA- 
CGTA-5' 
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Figure 1. Jurkat TAg cells 
were transfected with 20 I.tg of 
either (A) 4XAP-1 luc, (/3) 
3×NF-AT luc, (C) 3×NF-KB 
luc, or (D) 4XARRE luc and 40 
lag of either control vector 
D pCDNA3 or expression con- 
structs for p65 or c-rel. After 2 d, 
i l  4xARRE luc 10 s live cells (~1/50 of the total 
cells from each transfection) was 
examined for luciferase activity. 
The results represent the average 
"~15] of three independent transfec- 
tions. Within each experiment, 
the fold activation was calculated 
for each construct relative to the 
luciferase activity of the construct 
transfected with pCDNA3 alone. 
Error bars reflect the standard er- 
ror of the mean. Note that he 
pCDNA3 p65 c-rel scale is different in (C). 
To generate KKK: 
5'-TGAACCAACAAGAAGTAAAAGAAGCTATT-3' 
3'-CCCATAAGCTACACACTTGGTTGTTCT-5' 
Cell Culture, Transfections, and Stimulations. Jurkat TAg cells (pro- 
vided by Dr. G. Crabtree) were grown in RPMI supplemented 
with 10% fetal calf serum. The total amount ofDNA transfected 
within each experiment was kept constant by addition of the vec- 
tor pCDNA3 where appropriate. 1 × 107 Jurkat TAg cells were 
transfected ina total volume of 0.4 ml in RPMI (without fetal calf 
serum) by electroporation using a BioRad Gene Pulser Electro- 
porator set at 250 V, 960 p+F. 2 d after transfection (40-48 h), t e 
number of live cells within each sample were counted by Trypan 
blue exclusion. Luceriferase assays were performed in triplicate 
within each experiment using 1 × 10 s live cells in a total volume 
of 90 btl. Typically, this represents 1/50 of the total live cells re- 
covered after 2 d. Samples were stimulated, where appropriate, 
for 6 h with a 1:1,000 dilution of C305 ascites (anti-clonotypic 
Jurkat TCR) or a combination of50 ng/ml PMA and 1 DM iono- 
mycin (Calbiochem Novabiochem, San Diego, CA). All transfec- 
tions were done on three separate occasions, and the results rep- 
resent he average of three independent transfections, with the 
error bars representing the standard error from the mean. 
Luciferase Assays. To the 90-t*1 cell sample (containing 1 × 
105 live cells), 10 ~1 of cell harvest buffer containing 10% Triton 
X-100, 4 mM DTT, and 200 mM NaPO4, pH 7.8, and 100 I*l of 
assay buffer containing 200 mM NaPO4, pH 7.8, 20 mM MgC12, 
and 10 mM ATP was added. Luciferase activity was measured af- 
ter luciferin addition either manually or in a microplate lumi- 
nometer. 
Results 
c-rel Overexpression Activates AP- I ,  but Not NF-AT  or 
ARRE-1 Reporter Constructs. To determine whether c-Rel 
could regulate IL-2 gene expression by increasing the ac- 
tivity of transcription factors involved in IL-2 promoter 
regulation, c-Rel was overexpressed in transient transfection 
assays using Jurkat TAg cells in combination with reporter 
constructs containing NF-AT, ARRE-1 (Oct/OAP), AP-1, 
and NF-KB sites. The empty vector pCDNA3 was in- 
cluded as a negative control. The related NF-KB family 
member p65 was also included to determine whether c-Rel 
and p65 could differentially regulate these reporter con- 
structs. As shown in Fig. 1 A, c-Rel dramatically enhanced 
AP-1 reporter activity, ~17-fold greater than vector alone. 
This upregulation was in the absence of any stimuli. In 
contrast, p65 overexpression had a milder effect on AP-1 
reporter activity, enhancing it approximately fourfold. These 
results are consistent with previous reports, where p65 
overexpression upregulated AP-1 reporter activity by ap- 
proximately fivefold (30). Therefore, c-Rel was a more po- 
tent activator of AP-1 reporter activity than p65. However, 
p65 was a better activator of an NF-KB reporter (Fig. 1 C) 
with ~100-fold greater activity than c-Rel. In contrast with 
the dramatic effects ofc-Rel overexpression AP-1 reporter 
activity, only minimal effects on NF-AT and ARRE-1 re- 
porter activity were observed (Fig. 1, B and D), although 
these reporters could be activated by a combination of PMA 
and ionomycin (data not shown). In addition, p65 overex- 
pression did not affect NF-AT or ARRE-1 reporter activ- 
ity. Therefore, c-Rel overexpression had the most dramatic 
effect on upregulating AP-1 activity, as compared with other 
transcription factors involved in regulating IL-2 promoter 
activity. 
Stimulation and c-Rel Overexpression Cooperate in AP- 1 Activa- 
tion. To determine whether AP-1 reporter activation de- 
pended on the extent of c-Rel expression, we performed a
dose response analysis. As shown in Fig. 2 A, activation of 
AP-1 activity increased proportionately with increasing 
amounts oftransfected c-Rel. Transfections u ing increasing 
amounts of p65 did not lead to a dose-dependent effect on 
AP-1 activity. Since AP-1 activity is also increased in stim- 
ulated T cells, we examined the effects of c-Rel overexpres- 
sion on TCR or PMA/ionomycin-mediated AP-1 activation. 
As shown in Fig. 2 B and 2 C, overexpression f c-Rel en- 
hanced AP-1 activation after stimulation with either anti- 
TCR antibodies or with a combination of PMA and iono- 
mycin. This effect appears to be additive, and titratable 
across c-Rel concentrations. Overexpression of p65 does 
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F igure  2. Jurkat TAg cells were transfected with 20 Ixg of4XAP-1 luc 
and either 40 Ixg of control vector pCDNA3 or increasing amounts (5 Ixg, 
10 btg, or 20 Ixg) of p65 or c-rel expression constructs. In all cases, 
pcDNA3 was added where appropriate to standardize the total amount 
of DNA transfected to 60 txg total per sample. After 2 d, 105 live cells 
(~1/50 of the total cells from each transfection) were left nnstimulated, 
or stimulated with either 1:1,000 dilution of C305 anti-TCR ascites or 50 
mg/ml PMA with 1 I~M ionomycin. After 6 h, the cells were examined 
for luciferase activity. The results represent the average of three indepen- 
dent transfections. The fold activation was calculated relative o the lu- 
ciferase activity of unstimulated cells transfected with pCDNA3 alone. 
Error bars reflect the standard error of the mean. Note that the scale is dif- 
ferent in each graph. 
not  increase AP-1 activity in response to e i ther  ant i -TCR 
antibodies or w i th  PMA/ ionomyc in .  Therefore,  c -Re l  in-  
creases the amount  o f  AP-1 activity in the presence or ab-  
sence o f  addit ional  stimuli such as via the TCR or pharma-  
cologic agents. 
Overexpression of c-Rel also Increases the Activity from the AP-1 
Site of the IL-2 Promoter (NF-IL-2B). As descr ibed above, 
even though c-P~el appears to be a potent  activator o f  AP-1,  
c -Re l  had little effect on  e i ther  NF-AT  or ARRE reporter  
constructs (see Fig. 1). However ,  both  the NF-AT  site and 
the ARRE-1  site conta in  nonconsensus  b ind ing  sites for 
AP-1,  and AP-1 has been demonstrated to b ind to these sites 
after T cell activation. Addit ional ly,  there is another  non-  
A Ccmsermus AP-I: T~TCA 
AP-1 (NF-IL-2B) : AGAGIV.A 
AP-1 (NFAT) : ~,-~-,x;A 
AP-1 (ARI~) : TGTGTAA 
B 
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iPC p65 c-relj[pC p65 c-relllPC p65 c-relj 
4xAPol 4xAP-1 5xAP-1 
(NF-IL-2B) luc (NFAT) luc (ARRE-1) luc 
F igure  3. (A) The sequence of the AP-1 sites from the distal NF-AT 
site, the ARIkE-1 site, and the NF-IL-2B site from the IL-2 promoter is 
compared with the consensus AP-1 sequence. (B) Jurkat TAg cells were 
transfected with 20 txg of either 4×AP-I(ARRE) luc, 5×AP-I(NF-AT) 
luc, or 4×AP-I(NF-IL-2B) luc and 40 p,g of either control vector 
pCDNA3 or expression constructs for p65 or c-rel. After 2 d, 1 × 105 live 
cells (~1/50 of the total cells from each transfection) was examined for 
luciferase activity. The results represent the average of either two (4 X AP- 
I[NF-IL-2B] luc) or three (4×AP-I[NF-AT] luc or 4XAP-I[AP, RE] 
luc) independent transfections. Within each experiment, the fold activa- 
tion was calculated for each construct relative to the luciferase activity of 
the construct transfected with pCDNA3 alone. Error bars reflect the stan- 
dard error of the mean. 
consensus AP-1 site in the IL-2 promoter ,  the NF- IL -2B  
site. To examine the effects o fc -Re l  overexpression on AP-1 
sites f rom the IL-2 promoter  specifically, reporter  con-  
structs conta in ing only the AP-1 sites f rom either the distal 
NF -AT  site, the ARRE-1  site, and the NF- IL -2B  AP-1 
site were  created. A compar ison  o f  these AP-1 sites is 
shown in Fig. 3 A. As shown in Fig. 3 B, the act ivat ion of  
c -Re]  on  the nonconsensus  NF- IL -2B  AP-1 reporter  was 
signif icant but  less than observed w i th  the consensus AP-1 
reporter  (see Fig. 1 A), 6- fo ld as compared  w i th  17-fold, 
respectively. However ,  a l though c -Re l  mediated act ivat ion 
on  the nonconsensus  NF- IL -2B  AP-1 reporter  is weaker  
than on  a consensus AP-1 reporter, it is still greater than the 
effects o f  p65 overexpress ion on  a consensus AP-1 reporter  
(see Fig. 1 A; 30). This suggests that one  way c -Re l  may 
regulate IL-2 gene expression is th rough the NF- IL -2B  
AP-1 site. p65 overexpress ion had min imal  effects on  NF-  
IL -2B AP-1 reporter  activity. On ly  minor  effects are ob-  
served by c -Re l  or p65 overexpress ion on  ei ther  o f  report -  
ers constructed w i th  the nonconsensus  AP-1 sites f rom the 
distal NF -AT  or ARRE-1  sites. It should be noted  that 
these nonconsensus  AP-1 e lements may not  funct ion  w i th -  
out  the adjacent NF-AT  or Octamer  sites. Indeed, AP-1 is 
unable  to b ind  to the distal NF -AT  site in the absence o f  
NF -AT  prote in  (33). There fore ,  these AP-1  sites f rom 
NF-AT  and ARRE-1  may not  funct ion  as independent  
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Figure 4. (A) Shown schematically are various deletion mutants and 
site-directed mutants of c-rel relative to wild-type. Th  lighter NH2-ter- 
minal half of c-rel represents the rel domain, which is involved in DNA 
binding and dimerization. The darker COOH-terminal half of c-rel con- 
tains the transactivation domains. The X marks the placement of the mu- 
tated residues within c-rel. (B) Jurkat TAg cells were tramfected with 20 }*g 
of4×AP-1 luc and 40 ~g of either control vector pCDNA3 or different 
expression constructs for wild-type or mutant c-rel. After 2 d, 1 × 10 s live 
cells (~1/50 of the total cells from each transfection) was examined for 
luciferase activity. The results represent the average of three independent 
transfections. Within each experiment, the fold activation was calculated 
for each construct relative to the luciferase activity of4×AP-1 luc trans- 
fected with pCDNA3 alone. Error barseflect the standard error of the 
mean. 
AP-1 sites, which may reflect the lack of  activation by ei- 
ther c-Rel  or p65 overexpression. These results uggest one 
way through which c-Rel  may regulate IL-2 gene tran- 
scription, through activation of  the NF- IL -2B AP-1 site. 
Both the DNA Binding Domain and the Transactivation Do- 
mains of c-Rel Are Required for AP-1 Activation. To deter- 
mine which domains of  c-Rel  were responsible for upreg- 
ulating AP-1 reporter activity, various c-Rel  mutants were 
generated (shown schematically in Fig. 4 A). c-Rel  1-307 
consists of  only the Rel  domain, which contains the DNA 
binding and dimerization sequences as well as the nuclear 
localization signal but lacks all previously described activa- 
tion domains (31). c -Rel  187-587 has a deletion within the 
DNA binding domain of  c-Rel,  but contains the dimeriza- 
tion domain, nuclear translocation signal, and transactivation 
domains (31). c-Rel  RxxRxR and KKK recreate specific 
DNA binding mutants that were originally described by 
Kumar et al. (32) in v-Rel. The homologous residues within 
the p50 tel homology domain were found in the crystal 
structure to be specific DNA contact residues (34), suggest- 
ing that these mutations eliminate DNA binding by alter- 
ing direct interactions rather than by indirect structural per- 
turbations. As shown in Fig. 4 B, elimination of  either the 
1667 Shapiro et al. 
DNA binding domain, by either deletion or specific muta- 
tion, or the transactivation domains abolished the ability of  
c -Rel  to increase AP-1 activity. Therefore, both of  these 
domains are critical for the activation of AP-1 by c-Rel.  
Discuss ion  
We have demonstrated that c-Rel substantially upregulates 
activity of an AP-1 reporter. This effect is not observed with 
either an NF-AT  or ARRE-1  reporter. Moreover, c-Rel can 
activate an AP-1 reporter constructed from the NF- IL-2B 
site of  the IL-2 promoter. The activation of  AP-1 by c-Rel  
required both the DNA binding and transactivation domains 
of  c-Rel.  These data suggest hat c-Rel  is not increasing 
AP-1 reporter activity by functioning as a coactivator. If 
c -Rel  functions as a coactivator, one would expect to be 
able to mutate the DNA binding domain of  c-Rel  and still 
increase AP-1 reporter activity when overexpressed. How-  
ever, as shown in Fig. 4 B, two distinct site-directed mu-  
tants of  c-Rel  that specifically disrupted DNA binding did 
not upregulate activity from an AP-1 reporter. Addit ion- 
ally, we attempted to determine whether c-Rel  could bind 
directly to AP-1 family members bound to an AP-1 oligo- 
nucleotide in gel mobil ity shift assays. Using a recombinant 
GST-c-rel fusion protein, we were unable to demonstrate a 
shift in the AP-1 complexes when GST-c-rel was added 
(data not shown). These data argue against, although not 
eliminate, the possibility that c-rel is functioning as a coac- 
tivator to upregulate AP-1 activity. It is also possible that 
c-rel mediates the AP-1 activation indirectly, b  increasing 
expression of  a cytokine or other soluble factor, which, in 
turn, upregulates AP-1 activity. However,  mixing experi- 
ments argue against his idea. Specifically, Jurkat TAg cells, 
transfected either with 4XAP-1 luc or with a c-rel expres- 
sion vector, were mixed together. Upregulation of  AP-1 
activity would have implicated a soluble factor in c-rel- 
mediated AP-1 activation. However, no activation of  AP-1 
was detected (data not shown). Therefore, it does not ap- 
pear that c-rel mediates AP-1 activation by functioning as a 
coactivator, by binding directly to AP-1 sites, or by pro-  
ducing a cytokine or other soluble factor, which, in turn, 
feeds back to increase AP-1 activity. 
In activated T cells, AP-1 activity is regulated by two 
mechanisms: levels of  AP-1 family members (fos/jun) are 
transcriptionally upregulated and their relative activity is in- 
creased by phosphorylation (35). Since c-rel is a transcrip- 
tion factor, c-rel may upregulate AP-1 activity directly by 
increasing AP-1 protein levels through an increase in tran- 
scription of  AP-1 family members. However, we were un- 
able to detect either an increase in AP-1 levels using gel 
mobil ity shift assays or an increase in the protein levels of  
fos/jun family members by Western blot analyses from c-Rel 
overexpressing transiently transfected Jurkat TAg cells (data 
not shown). This may be due to limitations within our 
transient expression system. Since we are unable to detect 
AP-1 protein in transiently transfected cells, we also cannot 
examine an alternate possibility in which c-rel activates 
AP-1 through increased phosphorylation, c-rel and JNK1 
have been reported to interact in vivo, although the func- 
tional significance of  this interaction is not known (36). It is 
possible that c-rel could directly or indirectly activate JNK1 
to influence AP-1 reporter activity. The elucidation of  the 
mechanism by which c-rel increases AP-1 activity will de- 
pend on the development of  a stable, inducible c-rel over- 
expression system, which is currently under investigation. 
The critical role for c-rel in IL-2 gene expression was 
discovered using mice deficient for c-tel. Interestingly, this 
phenotype of  mature T cells in the c-tel-deficient mouse, 
characterized by an inability to produce IL-2 and prolifer- 
ate in response to stimuli, closely resembles what is ob- 
served in anergic T cell clones (reviewed in 37-38). The 
failure of  anergic T cell clones to produce IL-2 is due to an 
inability to upregulate AP-1 activity after stimulation (39), 
demonstrating the essential role of  AP-1 in IL-2 gene in- 
duction. Our  results how that c-rel overexpression leads to 
increased AP-1 activity. Therefore, the failure of  T cells 
from c-tel deficient mice to produce IL-2 may be due, at 
least in part, to a secondary decrease in AP-1 activation. 
The activation of  AP-1 by c-rel provides one mechanism 
by which c-rel functions to regulate IL-2 gene expression. 
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